CJC-1295 With DAC

This long-acting GHRH analogue has been studied for sustained stimulation of growth hormone and IGF-1. The research clarifies endocrine signaling; downstream benefits for recovery or body composition require their own clinical evidence.

Research focus & potential applications

GH signaling

IGF-1 response

What the research shows

Explore the selected studies, their findings and their limits.

Read the findings & sources

Human study discussed

Randomized studies in healthy adults found sustained increases in growth hormone and IGF-1 after long-acting CJC-1295. These are hormone measurements, rather than evidence of stronger muscles, better sleep or faster healing. The studied albumin-binding DAC form is distinct from compounds marketed as CJC-1295 without DAC.

PubMed · 16352683

For more information, contact info@aurevixpeptides.com.

Editorial review: September 23, 2026